Survival and prognostic analysis of T-cell lymphoblastic lymphoma patients treated with dose-adjusted BFM-90 regimen

Hui Yu; Lan Mi; Fei Qi; Xing Wang; Yingying Ye; Miaomiao Li; Dedao Wang; Ning Ding; Xiaogan Wang; Yuqin Song; Jun Zhu; Yan Xie

doi:doi:10.18632/aging.204008

← Back

Research Paper Volume 14, Issue 7 pp 3203—3215

Survival and prognostic analysis of T-cell lymphoblastic lymphoma patients treated with dose-adjusted BFM-90 regimen

Figure 1. Survival and conditional survival curves. (A) Overall survival and progression free survival after diagnosis. (B) Overall survival and progression free survival conditional on having survived 1, 2, 3, and 5 years after treatment in total 145 patients.